These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22105597)

  • 21. A case of Philadelphia-chromosome positive chronic idiopathic myelofibrosis.
    Chen F; Zhang C; Wang W; Li L; Yan S; Sun J; Zhang M; Ji C; Hou M
    Leuk Res; 2008 Apr; 32(4):665-7. PubMed ID: 17854891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of telomere's length and telomerase activity in Philadelphia chromosome negative myeloproliferative neoplasms.
    Spanoudakis E; Bazdiara I; Pantelidou D; Kotsianidis I; Papadopoulos V; Margaritis D; Xanthopoulidis G; Moustakidis E; Mantzourani S; Bourikas G; Tsatalas C
    Leuk Res; 2011 Apr; 35(4):459-64. PubMed ID: 20828816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular pathophysiology of Philadelphia-negative myeloproliferative disorders: beyond JAK2 and MPL mutations.
    Vannucchi AM; Guglielmelli P
    Haematologica; 2008 Jul; 93(7):972-6. PubMed ID: 18591622
    [No Abstract]   [Full Text] [Related]  

  • 24. Functional and genetic aberrations of in vitro-cultured marrow-derived mesenchymal stromal cells of patients with classical Philadelphia-negative myeloproliferative neoplasms.
    Avanzini MA; Bernardo ME; Novara F; Mantelli M; Poletto V; Villani L; Lenta E; Ingo DM; Achille V; Bonetti E; Massa M; Campanelli R; Fois G; Catarsi P; Gale RP; Moretta A; Aronica A; Maccario R; Acquafredda G; Lisini D; Zecca M; Zuffardi O; Locatelli F; Barosi G; Rosti V;
    Leukemia; 2014 Aug; 28(8):1742-5. PubMed ID: 24618733
    [No Abstract]   [Full Text] [Related]  

  • 25. The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders.
    Larsen TS; Christensen JH; Hasselbalch HC; Pallisgaard N
    Br J Haematol; 2007 Mar; 136(5):745-51. PubMed ID: 17313377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JAK2 V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders.
    Rossi D; Deambrogi C; Capello D; Cerri M; Lunghi M; Parvis G; Saglio G; Gaidano G; Cilloni D
    Br J Haematol; 2006 Oct; 135(2):267-8. PubMed ID: 16956348
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytogenetics might elucidate the etiology of acute transformation of chronic myeloproliferative syndromes without a Philadelphia chromosome. A brief report from a multicenter study by the Group Français de Cytogénétique Hématologique.
    Eur J Haematol; 1989 Jul; 43(1):86-7. PubMed ID: 2670606
    [No Abstract]   [Full Text] [Related]  

  • 28. [Unclassified chronic myeloproliferative Ph(-); i(17q); +8 syndrome with mixed myelo-megakaryoblastic crisis--case report].
    Mariańska B; Apel D; Seferyńska I; Maj S
    Acta Haematol Pol; 1996; 27(1):85-8. PubMed ID: 8629449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age at diagnosis is an important prognostic factor in Philadelphia-negative Myeloproliferative Neoplasms.
    Accurso V; Santoro M; Siragusa S
    Eur J Haematol; 2019 Aug; 103(2):140-141. PubMed ID: 31121064
    [No Abstract]   [Full Text] [Related]  

  • 30. Recent advances in biological and therapeutic aspects of myeloproliferative disorders.
    Mancini M; Diverio D; Alimena G; Mandelli F
    Curr Opin Hematol; 1994 Jul; 1(4):261-7. PubMed ID: 9371292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translocation t(8;13) in a patient with T cell lymphoma and features of a myeloproliferative syndrome.
    Behringer D; Schaefer HE; Kunzmann R; Mertelsmann R; Dölken G
    Leukemia; 1995 Jun; 9(6):988-92. PubMed ID: 7596190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The myeloid disorders: background.
    Swansbury J
    Methods Mol Biol; 2003; 220():23-42. PubMed ID: 12744204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.
    Kvasnicka HM; Thiele J
    Pathobiology; 2007; 74(2):63-71. PubMed ID: 17587877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic myeloproliferative disorders: a tyrosine kinase tale.
    De Keersmaecker K; Cools J
    Leukemia; 2006 Feb; 20(2):200-5. PubMed ID: 16341034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase.
    Cherington C; Slack JL; Leis J; Adams RH; Reeder CB; Mikhael JR; Camoriano J; Noel P; Fauble V; Betcher J; Higgins MS; Gillette-Kent G; Tremblay LD; Peterson ME; Olsen JJ; Tibes R; Mesa RA
    Leuk Res; 2012 Sep; 36(9):1147-51. PubMed ID: 22578777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983-99.
    Johansson P; Kutti J; Andréasson B; Safai-Kutti S; Vilén L; Wedel H; Ridell B
    J Intern Med; 2004 Aug; 256(2):161-5. PubMed ID: 15257729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms.
    Najfeld V; Cozza A; Berkofsy-Fessler W; Prchal J; Scalise A
    Exp Hematol; 2007 Nov; 35(11):1668-76. PubMed ID: 17976519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reduction of Ph1 chromosome in atypical myeloproliferative disorder by intensive chemotherapy].
    Takeyama H; Yano K; Fukutani H; Yamamoto F; Watanabe E; Satake T
    Rinsho Ketsueki; 1986 Sep; 27(9):1640-4. PubMed ID: 3468279
    [No Abstract]   [Full Text] [Related]  

  • 39. Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms.
    Dunlap J; Kelemen K; Leeborg N; Braziel R; Olson S; Press R; Huang J; Gatter K; Loriaux M; Fan G
    Am J Clin Pathol; 2011 May; 135(5):709-19. PubMed ID: 21502425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Special edition myeloproliferative neoplasia - disease pathogenesis and treatment options.
    Wolf D; Rumpold H
    Curr Cancer Drug Targets; 2011 Jan; 11(1):1-2. PubMed ID: 21288201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.